Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new HPLC method for pidotimod plasma levels determination

L Dal Bo1, G P Broccali, S Silingardi

  • 1B.T. Biotecnica Srl, Saronno (Va), Italy.

Bollettino Chimico Farmaceutico
|April 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editor's Choice - Management of Descending Thoracic Aorta Diseases: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS).

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2017
Same author

Antiplatelet Therapy in Carotid Artery Stenting and Carotid Endarterectomy in the Asymptomatic Carotid Surgery Trial-2.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2016
Same author

Transealing: a novel and simple technique for embolization of type 2 endoleaks through direct sac access from the distal stent-graft landing zone.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2014
Same author

INCRAFT® Stent-Graft System: one-year outcome of the INNOVATION Trial.

The Journal of cardiovascular surgery·2013
Same author

BRAVISSIMO: 12-month results from a large scale prospective trial.

The Journal of cardiovascular surgery·2013
Same author

Endovascular treatment of descending thoracic aneurysms.

HSR proceedings in intensive care & cardiovascular anesthesia·2013

This study presents an improved HPLC method for quantifying Pidotimod (PGT/1A), a biological response modifier, in plasma. The new method offers greater accuracy and a lower detection limit than previous techniques.

Area of Science:

  • Pharmacology
  • Analytical Chemistry
  • Biochemistry

Background:

  • Pidotimod (3-L-pyroglutamyl-L-thiazolidine-4-carboxylic acid; PGT/1A) is a novel biological response modifier.
  • Accurate quantification of Pidotimod in biological matrices is crucial for pharmacokinetic and pharmacodynamic studies.

Purpose of the Study:

  • To develop and validate a sensitive High-Performance Liquid Chromatography (HPLC) method for determining Pidotimod concentrations in human plasma.
  • To establish a more efficient and reliable analytical technique compared to existing methods.

Main Methods:

  • Utilized an Aminex Ion Exclusion HPX 874 column with a PRP precolumn.
  • Employed a mobile phase of 0.05% sulfuric acid-acetonitrile (88:12, v/v) at a flow rate of 0.6 ml/min.
  • Incorporated Oxiracetam as an internal standard for enhanced accuracy and employed UV detection at 210 nm.

Related Experiment Videos

Main Results:

  • The HPLC method demonstrated reliable recovery, accuracy, and reproducibility.
  • Achieved distinct retention times for Pidotimod (16.5 min) and Oxiracetam (13.8 min).
  • The method's lower detection limit surpasses previously described techniques.

Conclusions:

  • The developed HPLC method provides a validated, sensitive, and accurate means for Pidotimod quantification in plasma.
  • This improved analytical approach facilitates further research into Pidotimod's biological activity and therapeutic potential.
  • The use of an internal standard significantly enhances the reliability of Pidotimod plasma level determination.